CODXCo-Diagnostics Inc

Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plans FDA 510(k) and CLIA waiver submissions.read more...

Co-Diagnostics Vector Smart Division Expands Footprint to 21 States Co-Diagnostics Vector Smart Division Expands Footprint to 21 States PR Newswire SALT LAKE CITY, June 25, 2026 Expansion coincides with Co-Dx webinar for prospective mosquito abatement district customers in honor of National...

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line PR Newswire SALT LAKE CITY, June 18, 2026 Visit has included...

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx PCR Pro with Mexico Distributor Agreement Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx PCR Pro with Mexico Distributor Agreement PR Newswire SALT LAKE CITY, June 11, 2026 Longstanding...

Investors remained hopeful about U.S.-Iran talks, offsetting recent military exchanges.

Co-Diagnostics shares surged nearly 80% on Tuesday after the company expanded development efforts for a PCR test targeting the Bundibugyo strain of the Ebola virus.

Wall Street’s speculative engine is running hot as investors pile into AI infrastructure, autonomous driving, biotech innovation, and advanced manufacturing plays driving some of the market’s biggest momentum stories. $HTT, $NTHI, $HLIT, $CODX, $RDW, $PONY, $MOD, $BAC, $STT, $BCS

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara PR Newswire SALT LAKE CITY, May 26, 2026 Joint development strategy has been developed to address international deployment...

As capital continues flowing into high-growth sectors tied to artificial intelligence, biotechnology, diagnostics, and defense technology, several emerging companies are rapidly capturing investor attention through financings, acquisitions, regulatory approvals, and platform expansion strategies. $SBFM, $TGNT, $CODX, $JUNS, $VIDA, $QUCY, $GFS, $GOOG, $MSFT, $NVDA